Medicine and Dentistry
Low Drug Dose
100%
Graft Versus Host Reaction
100%
Thymocyte Antibody
100%
Cumulative Incidence
10%
Recurrence Free Survival
5%
Overall Survival
5%
Multivariate Analysis
5%
Prospective Study
5%
Cyclosporine
5%
Bloodstream Infection
5%
Allograft
5%
Chronic Graft Versus Host Disease
5%
Myeloid Leukemia
5%
Myelodysplastic Syndrome
5%
Drug Megadose
5%
Epstein Barr Virus
5%
Viremia
5%
Acute Graft Versus Host Disease
5%
Optimal Drug Dose
5%
Posttransplant Lymphoproliferative Disease
5%
Non-Relapse Mortality
5%
Myeloablative Conditioning
5%
Immunology and Microbiology
Low Drug Dose
100%
Graft-Versus-Host Disease
100%
Anti-Thymocyte Globulin
100%
Recurrence Free Survival
5%
Overall Survival
5%
Myeloid
5%
Ciclosporin
5%
Drug Megadose
5%
Chronic Graft Versus Host Disease
5%
Lymphoproliferative Disorders
5%
Viremia
5%
Conditioning
5%
Acute Graft Versus Host Disease
5%
Epstein Barr Virus
5%
Allograft
5%
Optimal Drug Dose
5%
Pharmacology, Toxicology and Pharmaceutical Science
Graft Versus Host Reaction
100%
Thymocyte Antibody
100%
Recurrence Free Survival
5%
Overall Survival
5%
Ciclosporin
5%
Prospective Study
5%
Bloodstream Infection
5%
Myelodysplastic Syndrome
5%
Chronic Graft Versus Host Disease
5%
Viremia
5%
Myeloid Leukemia
5%
Acute Graft Versus Host Disease
5%
Posttransplant Lymphoproliferative Disease
5%
Keyphrases
Fresenius
100%
Thymoglobulin
100%
Relapse Incidence
5%
Mismatched Related Donor
5%
CMV Reactivation
5%